Literature DB >> 17943460

Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist.

Edibaldo Silva1.   

Abstract

Women with a family history of breast cancer who are diagnosed with breast cancer are often counseled to undergo prophylactic mastectomy as part of their treatment for breast cancer. The majority of such individuals make these decisions in haste and without appropriate genetic counseling or testing. Most of them when tested for BRCA or other established mutations find that they are not mutation carriers. In retrospect, this realization leads many to question the wisdom of their prophylactic surgery which is often associated with complications and quality of life problems which they never envisioned. We have designed an algorithm for the management of these patients which minimizes these lifelong problems.

Entities:  

Mesh:

Year:  2007        PMID: 17943460     DOI: 10.1007/s10689-007-9167-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  25 in total

Review 1.  Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania.

Authors:  Gordon F Schwartz; Gabriel N Hortobagyi
Journal:  Cancer       Date:  2004-06-15       Impact factor: 6.860

Review 2.  Prevention and management of hereditary breast cancer.

Authors:  Steven A Narod; Kenneth Offit
Journal:  J Clin Oncol       Date:  2005-03-10       Impact factor: 44.544

3.  Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.

Authors:  Edibaldo Silva; Henry Lynch
Journal:  Breast J       Date:  2006 May-Jun       Impact factor: 2.431

4.  Implant reconstruction in breast cancer patients treated with radiation therapy.

Authors:  Jeffrey A Ascherman; Matthew M Hanasono; Martin I Newman; Duncan B Hughes
Journal:  Plast Reconstr Surg       Date:  2006-02       Impact factor: 4.730

5.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  H Meijers-Heijboer; B van Geel; W L van Putten; S C Henzen-Logmans; C Seynaeve; M B Menke-Pluymers; C C Bartels; L C Verhoog; A M van den Ouweland; M F Niermeijer; C T Brekelmans; J G Klijn
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

6.  Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

Authors:  L C Hartmann; T A Sellers; D J Schaid; T S Frank; C L Soderberg; D L Sitta; M H Frost; C S Grant; J H Donohue; J E Woods; S K McDonnell; C W Vockley; A Deffenbaugh; F J Couch; R B Jenkins
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

Review 7.  Preoperative (neoadjuvant) chemotherapy in patients with breast cancer.

Authors:  E P Mamounas; B Fisher
Journal:  Semin Oncol       Date:  2001-08       Impact factor: 4.929

8.  Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations.

Authors:  A Ganguly; K Leahy; A M Marshall; R Dhulipala; L Godmilow; T Ganguly
Journal:  Genet Test       Date:  1997

9.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

Authors:  N Wolmark; J Wang; E Mamounas; J Bryant; B Fisher
Journal:  J Natl Cancer Inst Monogr       Date:  2001

10.  Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Authors:  Lauren Scheuer; Noah Kauff; Mark Robson; Bridget Kelly; Richard Barakat; Jaya Satagopan; Nathan Ellis; Martee Hensley; Jeff Boyd; Patrick Borgen; Larry Norton; Kenneth Offit
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

View more
  11 in total

1.  Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.

Authors:  Kirsten F L Douma; Bettina Meiser; Judy Kirk; Gillian Mitchell; Christobel Saunders; Belinda Rahman; Mariana S Sousa; Kristine Barlow-Stewart; Margaret Gleeson; Kathy Tucker
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

2.  Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.

Authors:  E Zilliacus; B Meiser; M Gleeson; K Watts; K Tucker; E A Lobb; G Mitchell
Journal:  Support Care Cancer       Date:  2012-03-24       Impact factor: 3.603

3.  Ingredients for success: a familial cancer clinic in an oncology practice setting.

Authors:  Paul R Duncan; James T Lin
Journal:  J Oncol Pract       Date:  2011-01       Impact factor: 3.840

4.  The evolution of personalized cancer genetic counseling in the era of personalized medicine.

Authors:  Hetal S Vig; Catharine Wang
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 5.  Hereditary diffuse gastric cancer: prophylactic surgical oncology implications.

Authors:  Henry T Lynch; Edibaldo Silva; Debrah Wirtzfeld; Pamela Hebbard; Jane Lynch; David G Huntsman
Journal:  Surg Clin North Am       Date:  2008-08       Impact factor: 2.741

6.  Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.

Authors:  Marc D Schwartz; Beth N Peshkin; Claudine Isaacs; Shawna Willey; Heiddis B Valdimarsdottir; Rachel Nusbaum; Gillian Hooker; Suzanne O'Neill; Lina Jandorf; Scott P Kelly; Jessica Heinzmann; Aliza Zidell; Katia Khoury
Journal:  Breast Cancer Res Treat       Date:  2018-04-02       Impact factor: 4.872

7.  Family history in breast cancer in São Luís, Maranhão, Brazil.

Authors:  Maria Hilda Araújo Ribeiro; Marcos Antonio Custódio Neto da Silva; Walbert Edson Muniz Filho; Anna Cyntia Brandão Nascimento; Rodrigo Duart Martins Souza; Carlos Eduardo Everton Machado; Dulcelena Ferreira Silva; Geusa Felipa de Barros Bezerra; Graça Maria de Castro Viana; Maria do Desterro Soares Brandão Nascimento
Journal:  BMC Res Notes       Date:  2016-03-10

Review 8.  Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.

Authors:  Bettina Meiser; Kathy Tucker; Michael Friedlander; Kristine Barlow-Stewart; Elizabeth Lobb; Christobel Saunders; Gillian Mitchell
Journal:  Breast Cancer Res       Date:  2008-11-28       Impact factor: 6.466

9.  DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.

Authors:  Aisha S Sie; Liesbeth Spruijt; Wendy A G van Zelst-Stams; Arjen R Mensenkamp; Marjolijn J Ligtenberg; Han G Brunner; Judith B Prins; Nicoline Hoogerbrugge
Journal:  BMC Womens Health       Date:  2012-05-08       Impact factor: 2.809

10.  Improving the management of people with a family history of breast cancer in primary care: before and after study of audit-based education.

Authors:  Imran Rafi; Susmita Chowdhury; Tom Chan; Ibrahim Jubber; Mohammad Tahir; Simon de Lusignan
Journal:  BMC Fam Pract       Date:  2013-07-24       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.